Search

everythinglearnresearchcommunity

for

Search:↓

Some Greek melanoma patients have gene mutations linked to increased cancer risk, a new color feature helps diagnose melanoma, the incidence of a skin condition in the Netherlands is rare, and a gene possibly affects male-pattern baldness.

The mTOR pathway may be involved in the development of hair follicle tumors, with higher activity in malignant tumors.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

PTCH gene mutations contribute to basal cell carcinoma development.

Double-stranded RNA activates a pathway that causes a skin protein to be expressed in the wrong place.

A man with a rare scalp cancer was successfully treated, highlighting the need for early management to prevent spread and complications.

Bone marrow-derived cells contribute to skin tumors, suggesting new treatment targets for non-melanoma skin cancers.

MPA increases cancer spread by boosting Eph A2 activity.

Clouston syndrome can lead to skin cancer, so monitoring is crucial.

Twist1 is crucial for UVB-induced skin cancer development.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

First Korean case of Cronkhite-Canada syndrome with colon cancer and serrated adenoma.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Most U.S. keratinocyte carcinoma patients are older white males living in urban areas.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Truncated hHb1 keratin may play a role in breast cancer cell transformation.

SLCO genes may predict prostate cancer mortality risk, and lifestyle changes improve health in advanced prostate cancer.

Sun exposure and genetics increase skin cancer risk from precancerous lesions.

The extracellular matrix affects where tumors can start in the body.

Less differentiated melanoma cells are more vulnerable to a type of cell death, which could improve cancer treatments.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Connexin-26 gene mutations may increase cancer risk in KID syndrome patients.

Acne is not a key diagnostic feature for PCOS, postadolescent men with acne may have insulin resistance, melanoma patients often have few moles, tumor size in CSCC indicates higher risk of serious outcomes, and hidradenitis suppurativa is linked to higher risk of heart problems and death.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Mcl-1 can activate Wnt signaling in skin cells, promoting growth and possibly cancer.